In this podcast, our Chief Operations Officer & founder, John Waller, was invited onto the hugely popular Digital Pathology Today podcast.
John and the podcast host, Dr. Joseph Anderson, chat about OracleBio’s humble beginnings and our quantitative digital pathology journey over the past decade – from a single company laptop to a cutting-edge, scalable cloud computing infrastructure.
They covered a number of interesting topics, including:
- OracleBio’s history, mission, and field of practice
- Good Clinical Practice
- How Digital Pathology has evolved over the years and what its future holds
- Pathologist-led image analysis and the difficulties humans face with detailed quantification
- Artificial Intelligence: Machine Learning and Deep Learning
The importance of cloud computing and automation - …and a whole lot more!
Be sure to check out more episodes on the Digital Pathology Today website.
Reasons to Work With OracleBio:
Data you can trust – We have thorough quality control procedures in place throughout our workflow to ensure the data we provide is of a high-quality standard
Latest technologies – We continually invest time and money into the latest software and techniques so you don’t need to
More from OracleBio:
Utilizing AI to improve analysis accuracy and turnaround time for Preclinical tumor model IHC studies
⚡ Article Synopsis: In this article, we highlight a previous webinar case study where we utilized AI deep learning techniques to improve the accuracy and turn-around time for quantification of cytotoxic T-cell (CD8 marker), macrophage (F4/80 marker), and vasculature...
The use and value of the preclinical Bleomycin model in Drug Development for Idiopathic Pulmonary Fibrosis (IPF)
⚡ Article Synopsis: In this article, OracleBio has come together with one of our partners, TherapeutAix, who provide strategic and operational support for drug development projects, to provide our collective thoughts on the use and value of the preclinical Bleomycin...
Behind the Scenes: The Role of R&D in OracleBio
In July 2021, the creation of OracleBio’s dedicated Research & Development group marked an important milestone in our growth strategy. In this article, we go behind the scenes and take a retrospective look at what we have achieved over the past year, and give you...
Find out more about our Software Capabilities
OracleBio's Quantitative Digital Pathology Services
Stay up to date with OracleBio
Sign up to our mailing list to stay informed about news, webinars, events and more